Table 2. Patient and tumour characteristics.
RS: Recurrence Score generated through Oncotype DX testing; NPI: Nottingham Prognostic Index
| Number | % | Mean/median (range) | |
| Total tumours | 57 | - | - |
| Tumour size (cm), median (range) | - | - | 2.4 (0.4–8.5) |
| Grade 1 | 2 | 3.5 | - |
| Grade 2 | 26 | 45.6 | - |
| Grade 3 | 29 | 50.8 | - |
| Total patients | 46 | - | - |
| Patient age, mean (range) | - | - | 56 (35–75) |
| Cancer identified by symptomatic presentation | 32 | 69.6 | - |
| Cancer identified through screening | 14 | 30.4 | - |
| Patients with single tumours | 38 | 82.6 | - |
| Patients with multifocal disease | 8 | 17.4 | - |
| PREDICT score, median (range) | - | - | 3 (1–6) |
| Low (<3) | 22 | 47.8 | |
| Intermediate (3-5) | 22 | 47.8 | |
| High (>5) | 2 | 4.3 | |
| NPI score, median (range) | - | - | 3.4 (1.84–4.58) |
| Excellent (≤2.4) | 6 | 13 | - |
| Good (2.41–3.4) | 21 | 45.7 | - |
| Moderate (3.41–5.4) | 19 | 41.3 | - |
| Poor (≥5.41) | 0 | 0.0 | - |
| RS, median (range) | - | - | 1.7 (0–82) |
| Low (<18) | 24 | 52.2 | - |
| Intermediate (18-25) | 7 | 15.2 | - |
| High (>25) | 15 | 32.6 | - |